Title : Short-term clinical outcomes on a new dual-taper wedge femoral stem in total hip replacement
Abstract:
Abstract: The use of dual-tapered stems in total hip arthroplasty is not a new concept, and its popularity in the direct-anterior total hip approach has increased. This study analyzed the early clinical and radiological results of the Everglade stem (Signature Orthopedics NSW, Australia). A total of 100 patients (41 men and 59 women) were retrospectively studied and received 100 stems. The mean patient age was 68 years (interquartile range 62-76) at the time of surgery. The median follow-up was 161.5 days (interquartile range (43-187). The HOOS-Jr score improved from a mean 57.07 pre-operatively to a mean 86.03 at the 6-week visit and to 92.7 at the latest follow-up. At the 6-week X-ray assessment, we observed no incidence of stem subsidence, peri-prosthetic fracture, or radiolucencies. There were no cases of osteolysis and no stems were revised. According to our results, this short, dual-tapered stem shows a good short-term outcome. Prospective studies with longer follow-up are needed to assess the long-term survivorship of this stem fully.
Learning Points:
The Everglade stem is safe for total hip replacements.
The Everglade stem helped achieve excellent post-operative functional scores
In today’s environment of cost-savings and efficiency, the Everglade stem is an excellent option to use as a primary stem in hip replacement.
